Press Releases

Not on our mailing list? Sign up now!

Genxys TR8 PGX

APDN Partners with GenXys to Deploy Clinical Decision Support System for PGx Testing

June 18, 2024

TR8 PGX square logo

APDN Receives Approval for TR8™ PGx Testing from NYS Dept of Health

June 13, 2024

Micro RNA molecule illustration

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea™ IVT Platform

June 5, 2024

apdn circle logo

APDN Announces Pricing of $12 Million Public Offering

May 28, 2024

UHKT logo

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of APDN’s Linea DNA™ for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

May 13, 2024

apdn circle logo

APDN Announces Second Quarter Fiscal Year 2024 Financial Results

May 10, 2024

apdn circle logo

APDN Regains Compliance with Nasdaq Minimum Bid Price Requirement

May 10, 2024

HDT logo

APDN Awarded Contract by HDT Bio For Rapid Vaccine Development Program

April 25, 2024

apdn circle logo

Applied DNA Announces 1-For-20 Reverse Stock Split

April 22, 2024

Go to Top